1-12794199-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000332296.7(PRAMEF1):c.572C>T(p.Pro191Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000416 in 1,611,120 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P191S) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000332296.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRAMEF1 | NM_023013.4 | c.572C>T | p.Pro191Leu | missense_variant | 3/4 | ENST00000332296.7 | NP_075389.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRAMEF1 | ENST00000332296.7 | c.572C>T | p.Pro191Leu | missense_variant | 3/4 | 1 | NM_023013.4 | ENSP00000332134 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151488Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000519 AC: 13AN: 250256Hom.: 1 AF XY: 0.0000590 AC XY: 8AN XY: 135514
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1459632Hom.: 3 Cov.: 33 AF XY: 0.0000482 AC XY: 35AN XY: 726136
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151488Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 2AN XY: 73902
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.572C>T (p.P191L) alteration is located in exon 3 (coding exon 2) of the PRAMEF1 gene. This alteration results from a C to T substitution at nucleotide position 572, causing the proline (P) at amino acid position 191 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at